STAT
NOVEMBER 8, 2024
WASHINGTON — Pharmaceutical industry giant GSK plans to depart the biotechnology industry’s largest trade group, the Biotechnology Innovation Organization.
PharmaVoice
NOVEMBER 8, 2024
Past comments hint at the changes Robert F. Kennedy Jr. could make across the various sectors of healthcare.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
NOVEMBER 8, 2024
I am standing in front of my bathroom mirror trying to control my breathing. It is the morning after the election, and I learned the results when I woke about one hour ago. I had gotten up, showered, dressed, prepared breakfast and school lunches, ran to school drop-off, and returned home, a bit of a wreck with a few minutes to spare. I look down at my watch.
pharmaphorum
NOVEMBER 8, 2024
Eisai has scaled down its sales expectations for Alzheimer's disease drug Leqembi after sluggish sales growth in the first half of the current fiscal year.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
STAT
NOVEMBER 8, 2024
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is rather modest. We expect to continue the never-ending quest to manicure the Pharmalot grounds, promenade with the official mascots, and catch up on napping. We also hope to hold another listening party, where the rotation will likely include this , this , this , this and this.
pharmaphorum
NOVEMBER 8, 2024
AstraZeneca has revealed that its top executive in China, Leon Wang, has been detained by Chinese authorities
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
Express Pharma
NOVEMBER 8, 2024
Quantiphi, an AI-first digital engineering company, and DDReg, a global leader in regulatory expertise, have announced a partnership aimed at addressing regulatory challenges faced by pharmaceutical, biotechnology, medical device, and cosmetics manufacturers. The collaboration seeks to expedite the process of bringing innovations to market by utilising artificial intelligence.
STAT
NOVEMBER 8, 2024
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. And here is our regular feature in which we highlight a different person each week.
pharmaphorum
NOVEMBER 8, 2024
Wales has extended a scheme to harness the power of genomics to improve cancer care and prevention via an alliance with gene-sequencing giant Illumina.
Pharmaceutical Technology
NOVEMBER 8, 2024
A Phase III trial with the companies’ monoclonal antibody in patients with chronic rhinosinusitis with nasal polyps met its primary endpoint.
Advertisement
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
pharmaphorum
NOVEMBER 8, 2024
Daiichi Sankyo signs a $300m deal with Alteogen to develop a subcutaneous version of anti-HER2 cancer drug Enhertu.
The Pharmacist
NOVEMBER 8, 2024
GP leaders in England will vote on whether to lobby NHS England to ‘appropriately’ fund dispensing in community pharmacies and to put an end to pitting the two sectors against each other. The national Local Medical Committee (LMCs) conference later this month will debate a motion focused on the ‘necessity’ of community pharmacy. However, the […] The post GP leaders to debate community pharmacy funding appeared first on The Pharmacist.
Pharmaceutical Technology
NOVEMBER 8, 2024
The seemingly inexorable rise in global obesity is being reflected in the sales of diabetes and weight-loss drugs, including Ozempic.
pharmaphorum
NOVEMBER 8, 2024
The UK is squandering the vast resource of NHS patient data because too many obstacles are being placed in front of researchers trying to tap into it – holding back medical advances. That is the conclusion of the much-anticipated Sudlow Review – carried out by Prof Cathie Sudlow, chief scientist of Health Data Research (HDR) UK – which found that accessing patient data can take months or even years, hampering research into areas like dementia, cancer and heart disease.
Speaker: Joe Sharpe and James Carlson
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
Pharmaceutical Technology
NOVEMBER 8, 2024
Leqembi is approved for Alzheimer’s patients in multiple territories, but questions remain over its cost-effectiveness.
The Pharmacist
NOVEMBER 8, 2024
The government has announced another extension to the ban on the sale and supply of puberty blockers by private providers until 31 December. The emergency ban, brought in by former health secretary Victoria Atkins in May, was implemented following publication of the Cass Review, which concluded that children and young people seeking NHS care for gender-related […] The post Puberty blockers ban extended again appeared first on The Pharmacist.
BioPharma Dive
NOVEMBER 8, 2024
On the heels of its most advanced medicine flunking a key study, the drugmaker is looking at the different paths it could take to “maximizing stockholder value.
pharmaphorum
NOVEMBER 8, 2024
Conducting a cybersecurity audit on your pharmaceutical supply chain is crucial for protecting sensitive data. Learn how to properly assess and strengthen your cybersecurity measures with this guide.
Advertisement
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
BioPharma Dive
NOVEMBER 8, 2024
AstraZeneca and Amgen's drug could have a new use after positive Phase 3 study results. Elsewhere, Jazz set new plans for a narcolepsy drug and CDMO Avid Bioservices agreed to be taken private.
European Pharmaceutical Review
NOVEMBER 8, 2024
A study has reported a novel microbiology approach using TPX polymer film to culture bacteria in a liquid static culture. One key challenge of culturing in microbiology is that since oxygen does not dissolve easily in the liquid medium typically used during this process, the medium must be vigorously aerated, usually by shaking, which causes shear stress of the microorganisms, the Japanese researchers explained.
Pharmafile
NOVEMBER 8, 2024
BALVERSA (erdafitinib) has been granted marketing approval by the UK Medicines and Healthcare products Regulatory Agency (MHRA) for the treatment of the most common type of bladder cancer, metastatic or unresectable urothelial carcinoma. The treatment, produced by Johnson & Johnson, will be a monotherapy for adults with bladder cancer. The decision by the MHRA was […] The post Johnson & Johnson receive MHRA approval for BALVERSA appeared first on Pharmafile.
PharmaTech
NOVEMBER 8, 2024
Balversa (erdafitinib) marks the first and only bladder cancer therapy to target FGFR3 alterations, with a demonstrated increase in overall survival from 7.8 months to 12.1 months.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
PharmExec
NOVEMBER 8, 2024
The Varipulse platform includes a single-device workflow with minimal to zero fluoroscopy requirements, real-time imaging, and lesion tagging for paroxysmal atrial fibrillation.
PharmaTech
NOVEMBER 8, 2024
A £520 million investment for manufacturing capacity was announced by Chancellor of the Exchequer, Rachel Reeves, but academic and industry leaders stress the money should be used to train personnel.
PharmExec
NOVEMBER 8, 2024
Submissions to the FDA and EMA for new indication of Darzalex Faspro are based on results of the Phase III Aquila trial in patients with high-risk smoldering multiple myeloma.
pharmaphorum
NOVEMBER 8, 2024
Join the Patient Recruitment for Rare Disease Trials Summit hosted by Hanson Wade to connect with industry experts, share insights, and advance patient recruitment strategies for rare disease clinical trials.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
PharmExec
NOVEMBER 8, 2024
In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
Pharma and Life Sciences Blog
NOVEMBER 8, 2024
Transform Your Supply Chain: Address the Top 3 AI Challenges Vijendra Fri, 11/08/2024 - 19:37 While AI can revolutionize supply chain processes, the challenges are real. New research from GEP and Foundry pointed to three core hurdles to AI adoption — identifying valuable use cases, mastering data management and attracting skilled talent. For actionable insights to leverage AI’s power to boost efficiency and resilience, download 3 AI Adoption Pitfalls To Avoid in Procurement and Supply Chain Mana
PharmExec
NOVEMBER 8, 2024
In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
The Pharmacist
NOVEMBER 8, 2024
Adding in just five minutes of vigorous exercise to a daily routine can help lower blood pressure, a large study has concluded. Analysis of data from more than 14,700 people across five countries found that short periods of exercise that increases heart rate, such as cycling and climbing stairs, had a measurable benefit. Using fitness […] The post Just five minutes of vigorous exercise a day can lower blood pressure appeared first on The Pharmacist.
Pharmaceutical Technology
NOVEMBER 8, 2024
LakeShore Biopharma has commenced the submission of its biologics license application (BLA) to the Drug Regulatory Authority of Pakistan (DRAP) seeking conditional approval for its PIKA Rabies Vaccine for post-exposure prophylaxis (PEP).
Expert insights. Personalized for you.
343 
Let's personalize your content